Deciphera Pharmaceuticals: Q3 Earnings Insights

Deciphera Pharmaceuticals DCPH reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Deciphera Pharmaceuticals beat estimated earnings by 5.17%, reporting an EPS of $-0.55 versus an estimate of $-0.58.

Revenue was up $12.75 million from the same period last year.

Last quarter the company beat on EPS by $0.06 which was followed by a 1.78% drop in the share price the next day.

To track all earnings releases for Deciphera Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.